rs41315858

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001035.3(RYR2):​c.5654G>A​(p.Gly1885Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0233 in 1,609,734 control chromosomes in the GnomAD database, including 537 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1885A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.017 ( 25 hom., cov: 32)
Exomes 𝑓: 0.024 ( 512 hom. )

Consequence

RYR2
NM_001035.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:21

Conservation

PhyloP100: 0.388

Publications

25 publications found
Variant links:
Genes affected
RYR2 (HGNC:10484): (ryanodine receptor 2) This gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. [provided by RefSeq, Jul 2008]
RYR2 Gene-Disease associations (from GenCC):
  • arrhythmogenic right ventricular dysplasia 2
    Inheritance: AD Classification: DEFINITIVE, NO_KNOWN Submitted by: Laboratory for Molecular Medicine, Ambry Genetics
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
  • catecholaminergic polymorphic ventricular tachycardia 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the RYR2 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 195 curated pathogenic missense variants (we use a threshold of 10). The gene has 55 curated benign missense variants. Gene score misZ: 5.7809 (above the threshold of 3.09). Trascript score misZ: 6.4158 (above the threshold of 3.09). GenCC associations: The gene is linked to hypertrophic cardiomyopathy, catecholaminergic polymorphic ventricular tachycardia 1, catecholaminergic polymorphic ventricular tachycardia, arrhythmogenic right ventricular dysplasia 2, arrhythmogenic right ventricular cardiomyopathy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0018713474).
BP6
Variant 1-237614782-G-A is Benign according to our data. Variant chr1-237614782-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 36746.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0171 (2599/152334) while in subpopulation NFE AF = 0.0282 (1921/68024). AF 95% confidence interval is 0.0272. There are 25 homozygotes in GnomAd4. There are 1194 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2599 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR2NM_001035.3 linkc.5654G>A p.Gly1885Glu missense_variant Exon 37 of 105 ENST00000366574.7 NP_001026.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR2ENST00000366574.7 linkc.5654G>A p.Gly1885Glu missense_variant Exon 37 of 105 1 NM_001035.3 ENSP00000355533.2
RYR2ENST00000661330.2 linkc.5654G>A p.Gly1885Glu missense_variant Exon 37 of 106 ENSP00000499393.2
RYR2ENST00000609119.2 linkn.5654G>A non_coding_transcript_exon_variant Exon 37 of 104 5 ENSP00000499659.2

Frequencies

GnomAD3 genomes
AF:
0.0171
AC:
2600
AN:
152216
Hom.:
25
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00533
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0161
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.0140
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0283
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.0156
AC:
3828
AN:
245448
AF XY:
0.0154
show subpopulations
Gnomad AFR exome
AF:
0.00431
Gnomad AMR exome
AF:
0.00874
Gnomad ASJ exome
AF:
0.00830
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0150
Gnomad NFE exome
AF:
0.0263
Gnomad OTH exome
AF:
0.0180
GnomAD4 exome
AF:
0.0239
AC:
34852
AN:
1457400
Hom.:
512
Cov.:
31
AF XY:
0.0232
AC XY:
16835
AN XY:
724356
show subpopulations
African (AFR)
AF:
0.00342
AC:
114
AN:
33300
American (AMR)
AF:
0.00888
AC:
395
AN:
44464
Ashkenazi Jewish (ASJ)
AF:
0.00721
AC:
187
AN:
25948
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39626
South Asian (SAS)
AF:
0.00173
AC:
149
AN:
85948
European-Finnish (FIN)
AF:
0.0149
AC:
793
AN:
53260
Middle Eastern (MID)
AF:
0.00401
AC:
23
AN:
5734
European-Non Finnish (NFE)
AF:
0.0289
AC:
32028
AN:
1108950
Other (OTH)
AF:
0.0193
AC:
1161
AN:
60170
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
2104
4208
6311
8415
10519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1226
2452
3678
4904
6130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0171
AC:
2599
AN:
152334
Hom.:
25
Cov.:
32
AF XY:
0.0160
AC XY:
1194
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00531
AC:
221
AN:
41582
American (AMR)
AF:
0.0161
AC:
246
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4828
European-Finnish (FIN)
AF:
0.0140
AC:
149
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0282
AC:
1921
AN:
68024
Other (OTH)
AF:
0.0147
AC:
31
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
133
267
400
534
667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0220
Hom.:
101
Bravo
AF:
0.0161
TwinsUK
AF:
0.0337
AC:
125
ALSPAC
AF:
0.0306
AC:
118
ESP6500AA
AF:
0.00526
AC:
21
ESP6500EA
AF:
0.0234
AC:
195
ExAC
AF:
0.0149
AC:
1803
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.0264
EpiControl
AF:
0.0256

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:21
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
May 10, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Allele frequency = 2.4% (n=160 alleles), EA cohort, NHLBI ESP. -

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 08, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 21, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:6
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30403697, 25925909, 28798025, 28404607, 27153395, 21315846, 19926015, 24025405, 24237251, 18326664) -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RYR2: BP4, BS1, BS2 -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:2
May 11, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia Benign:1
Nov 20, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiomyopathy Benign:1
Mar 15, 2018
Color Diagnostics, LLC DBA Color Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arrhythmogenic right ventricular cardiomyopathy Benign:1
Nov 10, 2014
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Mar 25, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Arrhythmogenic right ventricular dysplasia 2 Benign:1
May 11, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
4.4
DANN
Benign
0.50
DEOGEN2
Benign
0.33
T;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.037
N
LIST_S2
Benign
0.81
T;T
MetaRNN
Benign
0.0019
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.60
N;.
PhyloP100
0.39
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.55
N;.
REVEL
Benign
0.090
Sift
Benign
0.89
T;.
Polyphen
0.0
B;.
Vest4
0.067
MPC
0.47
ClinPred
0.0052
T
GERP RS
-2.4
Varity_R
0.049
gMVP
0.11
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41315858; hg19: chr1-237778082; API